You are doing your very best to put down Fida...the bottom line is: Fida offers another alternative to Vanco for C.diificile with excellent efficacy, significantly lower relapse rate compared to Vanco...This alone makes Fida a worthwhile drug for FDA to fast track approve. Also, limitations of vanco therapy is developement of vanco resistance e-coli with prolonged use...therefore there is always a place for Fida....watch and learn..By the way, your math is waaaaaay off....
This Kamoa guy is eating too much plate lunches with fried pork and white bread. It's clogged his cognitive functioning.
At first I thought he was lying to cause fear in OPTR longs but now I think he really is that dumb.
OPTR's safety profile is impressive and this is why it will get approved. Unsafe, effective drugs usually do not get approved. OPTR has a drug that is both effective and safe. Perfect for a nice pop to $16 or $17.